SLU-PP-332 Capsules
$149.99
In stockSLU-PP-332 is an experimental estrogen-related receptor agonist investigated in preclinical models of mitochondrial metabolism, oxidative gene programs, skeletal-muscle physiology, and exercise-responsive signaling.
| SKU | RC-EE=SLUP332-60CT |
|---|---|
| Manufacturer | Exceed Enhancement |
| Form | Capsule |
| Strength | 20 mg |
| Size | 60 ct |
| Reported Result | Pending COA |
| Stock | In stock |
| Documentation Status | Pending Final COA |
Product Description
SLU-PP-332 is an investigational small molecule that activates estrogen-related receptors ERRα, ERRβ, and ERRγ. These receptors help regulate genes involved in energy metabolism and skeletal-muscle function. Researchers describe it as an “exercise mimetic” because it reproduces certain molecular responses associated with aerobic exercise in experimental models.
Research has focused on whether activating these pathways can influence endurance, fuel utilization, and metabolic health.
What research has shown:
Improved endurance in mice: Treatment increased exercise endurance and the proportion of type IIa oxidative muscle fibers, which contribute to sustained muscular activity. These findings have not established improved endurance in people.
Increased fat utilization: Mouse studies reported increased fatty-acid oxidation—the breakdown of fats for fuel—and increased energy expenditure without a measured increase in food intake.
Reduced fat accumulation in obesity models: Studies in obese mice reported reduced fat-mass accumulation and improvements in insulin sensitivity. These results support further metabolic research rather than proven human weight-loss or diabetes benefits.
Storage and handling: Protect from excessive heat, light, and moisture.
Third-party testing status.
| Batch / Lot | Reported Result | Tested | Partner | Status | Document |
|---|---|---|---|---|---|
| N/A | 96.99% | Feb 28, 2025 | Vanguard Laboratory | Complete | View COA |
.png)